Fremanezumab for prophylaxis of migraine in adults
Sign Up to like & getrecommendations! Published in 2020 at "Prescriber"
DOI: 10.1002/psb.1818
Abstract: Fremanezumab (Ajovy) is a new anti‐CGRP monoclonal antibody therapy indicated for the prophylaxis of migraine in adults. This article outlines its properties, efficacy, adverse effects and place in therapy. read more here.
Keywords: migraine adults; prophylaxis migraine; fremanezumab prophylaxis;
CGRP Antibodies as Prophylaxis in Migraine
Sign Up to like & getrecommendations! Published in 2018 at "Cell"
DOI: 10.1016/j.cell.2018.11.049
Abstract: Monoclonal antibodies against calcitonin gene-related peptide (CGRP) or its receptor (CLR + RAMP1) offer considerable improvements over existing drugs in migraine prophylaxis and are the first designed to act on the trigeminal pain system. Erenumab… read more here.
Keywords: cgrp; antibodies prophylaxis; cgrp antibodies; prophylaxis migraine ... See more keywords